Model
Edge
Revance Therapeutics Inc.
0001803375
Filing Type
4
Filing Date
9/6/2023
Updated
9/7/23, 11:37 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership